MenuMENU
Forum & Publications > Publications > Journal of Medical Toxicology > Policies

Policies

Contributorship GuidelinesConflict of Interest PolicyPlagiarism Policy | JMT Appeals Process

JMT Authorship and Contributorship Guidelines

Authorship

The Journal of Medical Toxicology (JMT) adheres to the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts (URM) guidelines on authorship.

In order to claim authorship of a manuscript submitted to JMT, the following conditions outlined in the URM must be met.

Authors must have contributed substantially to each of the three criteria:

  1. At least one of the following: conception and design, data acquisition, or interpretation and analysis of data.
  2. Drafting the article or revising it critically for important intellectual content.
  3. Final approval of the version to be published.

All persons claiming authorship must meet the above requirements and all those who meet the above requirements must be listed as authors [1].

Group Authorship

Sometimes, large numbers of individuals may contribute to a manuscript, as in a multi-center study. In order to be listed as an author, each individual must meet the URM authorship requirements above. If that is the case, the authors should form a group and the group’s name will be listed in the article byline and indexed by MEDLINE. Individual collaborators within will be published in the article text with acknowledgements and indexed by MEDLINE as collaborators [2].

The collaborating group should choose one or more authors who take primary public responsibility for the content of the published work and these authors should be listed in the article byline individually, in addition to the group’s name, as “guarantors” of the article’s content [3].

Order of Authorship

Order of authorship and the significance attributed to author order varies widely within scientific communities. JMT will publish all accepted works with the author order appearing as submitted in the final manuscript.

Contributorship

Persons who have made substantial contributions to a manuscript but do not meet the ICMJE URM requirements for authorship above may still be acknowledged in the published work. The names of these persons and their contributions should be submitted in the manuscript’s acknowledgements, with their specific contribution to the work. JMT suggests that contributors be listed in order of the relative importance of their contribution to the finished work, in descending order. For example, “PL performed statistical analysis of the data set, AS revised the draft manuscript, and LD provided departmental computer resources” [3].

Financial Disclosure

Financial or material support provided to the authors of any submitted work must be disclosed. Financial disclosure may be completed electronically via Editorial Manager at http://jmto.edmgr.com.

References

1. (2004) International Committee of Medical Journal Editors (ICMJE): Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. Haematologica 89(3):264.

2. United States National Library of Medicine (2008) Fact Sheet: Authorship in MEDLINE. In. http://www.nlm.nih.gov/pubs/factsheets/authorship.html Accessed 27 Feb 2013

3. Rennie D, Yank V, Emanuel L (1997) When authorship fails. A proposal to make contributors accountable. JAMA 278(7):579-85.

 

JMT Conflict of Interest Policy for Editors and Reviewers

Purpose:

To describe the policy and practice for management of editor and reviewer conflicts of interest involving The Journal of Medical Toxicology (JMT).

Policy:

A conflict of interest may occur when an editorial board member or reviewer has personal or outside financial, business, professional interests or other responsibilities that conflict with their duties to JMT, including decisions and reviews of manuscripts submitted to JMT. Editorial board members and reviewers are required to declare to JMT any actual or potential conflicts of interest.

Practice:

1. Definitions

a. Conflict of Interest: Any situation or transaction in which a person has a direct or indirect interest such that he/she may realize a personal benefit from the situation or transaction. This includes decisions to publish or not publish a manuscript.

b. Financial conflict of interest includes more than nominal compensation from an entity that has a financial interest or stake in the subject of a publication or other activity of JMT. Nominal in value means no more than twenty-five dollars ($25.00). Direct interest includes ownership by you or a member of your immediate family, or an investment in a concept, product or another party developing those concepts or products. Indirect interests involve consulting or accepting any type of compensation for work involving the concept or product or any company involved in the concept or product.

c. Non-financial conflict of interest includes personal (friendship, family members, co-workers, political, religious), and intellectual (competing research, fiduciary responsibilities) interests that would make a reasonable reader, author, reviewer or editor feel misled or deceived if not disclosed. These include friendship with an author, interest in competing organizations, competing research interests, or political beliefs or religious beliefs that could be perceived by a reasonable reader of JMT to interfere with your objectivity.

2. Procedures:

a. Annually, members of the editorial board will provide information regarding their potential conflicts of interest. This will include at a minimum financial conflicts of interest as defined above.

b. Reviewers assessing a manuscript for JMT will answer the following questions regarding that manuscript:
i. Indicate whether there are financial competing interests, either direct or indirect.
ii. Indicate whether there are personal competing interests.
iii. Indicate whether there are intellectual or fiduciary conflicts.

c. Evaluation
i. Each real or potential conflict of interest of a reviewer will be evaluated by the decision editor for the manuscript involved, assuming the decision editor does not have a conflict of interest.
ii. The decision editor may decide this potential conflict does not eliminate the value of the reviewer's opinion, and proceed, or choose another reviewer. This decision will be reported to JMT staff for record keeping.
iii. Each decision editor is expected to notify a deputy editor or the editor in chief if they have any potential conflict on a manuscript they are supervising.
iv. Each real or potential conflict of interest of a decision editor will be evaluated by the editor in chief or his designate, and their decision reported to JMT staff for record keeping.

d. Actions
i. Whenever a real or potential conflict of interest is declared, the evaluator will provide in writing a decision regarding the conflict.
ii. If a direct financial interest has been declared, the individual will typically be recused from participation in the refereeing of the manuscript involved.
iii. Lesser conflicts involving reviewers will be resolved at the discretion of the supervising editor. Conflicts involving a decision editor will be resolved by a deputy editor or the editor in chief.
iv. When the manuscript is published, the name of the decision editor will be published at the end of the article.
v. Permanent records will be kept of all potential conflicts of interest and the decisions as to how to handle them.

e. Complaints
A complaint regarding potential conflict of interest of a reviewer will be referred to the decision editor of that paper, who will review the circumstances and send a written assessment of the merits of the complaint to the editor in chief.

A complaint regarding potential conflict of interest of an editor will be referred to the associate editor, who will review the circumstances and send a written assessment of the merits of the complaint to the editor in chief. The editor in chief will make a final decision on management of the conflict and a written summary will be sent to JMT staff for record keeping.

In the Manuscript Submission Agreement, cite all affiliations or involvement that might be perceived as conflicts of interest. These include but are not limited to honoraria; education grants; speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements with any organization or entity with any financial interest in the subject matter or materials used in the research. If there are no such potential conflicts, the authors must declare this. If the manuscript is accepted, JMT will disclose the relevant information with the article. JMT has a detailed policy on this and other ethical issues

Other Conflicts of Interest: Potential conflicts of interest that might arise on the part of journal reviewers or editors are discussed separately. See ref [57]

 

JMT Plagiarism Policy (PDF)

 

JMT APPEALS PROCESS FOR AUTHORS

General

Authors may request an appeal of publication decisions rendered by a JMT Decision Editor or the Editor-in-Chief. This policy defines the process once the JMT Editorial office receives the appeal.

Qualifying Appeals

Appeals will be considered only if they assert that (1) an error of fact or substantial misunderstanding occurred, and/or (2) a disqualifying conflict of interest exists on the part of a reviewer, the Decision Editor, or Editor-in-Chief.

Appeals Process

All appeals must: (1) be made in writing to the Editor-in-Chief; (2) clearly state the basis for the appeal and provide substantiating information; and (3) be received by the JMT office within 30 days of the date of the letter of rejection.

The editorial staff will forward the appeal to the Editor-in-Chief or the Associate Editor within 5 business days. If unavailable, the Editor-in-Chief or Associate Editor may delegate this to another member of the Editorial Board not involved with the initial decision.

The Editor-in-Chief, the Associate Editor, or their designee will receive the initial and revised (if applicable) manuscripts, all referee reports, and all correspondences relating to the manuscript.

The Editor-in-Chief, the Associate Editor, or their designee will choose a disposition within 30 business days of receiving the above materials. The decision may be: (1) to reaffirm the initial decision and take no further action; (2) to overturn the initial decision and accept the manuscript or write a specific revise/reconsider letter; or (3) to decide that additional information is required. If additional information is required, then the manuscript will be sent, with no other background material, to at least two reviewers not associated with the previous review, following usual manuscript review operations/timelines.

The Editor-in-Chief, the Associate Editor, or their designee will consider all referee comments at this point to choose final disposition. This decision is final and the author will be notified in writing per usual mechanisms.